Dr William Holgerson This is Me

Education

 View all 6 references Web References

1. 1. www.nwpcmd.com

   www.nwpcmd.com/holgerson_bio.h - [Cached]

   Published on: 4/11/2006   Last Visited: 3/16/2007

   William Holgerson, MD
   
   Dr Holgerson is a graduate of the University of Notre Dame and the University of Massachusetts School of Medicine. He completed his residency program at the Newton Wellesley Hospital, where he served as Chief Medical Resident. Dr Holgerson is Board Certified in Internal Medicine and he is an associate Clinical Professor at Tufts University School of Medicine. Dr Holgerson is the founding partner of Newton Wellesley Primary Care, and has been selected three times by Boston Magazine as one of Boston's best primary care physicians. Dr. Holgerson and his wife, Barbara, live in Needham with their six children. Dr Holgerson is available for appointments in our Newton and Needham offices. Voted one of Tufts top Primary Care Physicians by his Tufts patients in 2002. Dr Holgerson is not accepting new patients at this time.

2. 2. Program Faculty

   www.nwh.org/webpage.cfm?site_i - [Cached]

   Published on: 1/24/2003   Last Visited: 1/24/2003

   William Holgerson, MD , University of Massachusetts Medical School (1975).  Instructor in Medicine, Tufts University School of Medicine.  Internship and residency in Medicine: Newton-Wellesley Hospital.  Certification: Internal Medicine.

3. 3. Designer Pills Aimed at the Consumer's Subconscious

   www.merckmedicus.com/pp/us/hcp - [Cached]

   Published on: 5/22/2001   Last Visited: 5/26/2001

   Dr. William Holgerson , an internist at Newton-Wellesley Hospital , said patients increasingly ask him about advertised medicines , and he has to spend time explaining why that pill may not be better than either cheaper generics or other options.
   
   ``We'd all be better served if there wasn't so much advertising , '' Holgerson said.
   
   Indeed , pharmaceutical advertising aimed at consumers has skyrocketed in recent years , reaching an estimated $ 2.5 billion last year , double the amount of the previous year. Health-care analysts say all these costs , including the price of pill design , get passed on in some form as higher drug prices.